China’s pharma stocks gain favours amid ‘greater’ progress of innovative drugs

Chinese pharmaceutical companies are ramping up global expansion and the sector, set to sustain rapid growth with the upcoming third-quarter earnings releases, could see a further lift in market sentiment, analysts said. In the first three quarters, domestic innovative drugs accounted for 80 per cent of all innovati…

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.